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PLoS BIOLOGY

Notch-Deficient Skin Induces a Lethal
Systemic B-Lymphoproliferative Disorder by
Secreting TSLP, a Sentinel for Epidermal Integrity
Shadmehr Demehri1,2*, Zhenyi Liu1, Jonghyeob Lee1,¤, Meei-Hua Lin3, Seth D. Crosby4, Christopher J. Roberts5,
Perry W. Grigsby6, Jeffrey H. Miner3, Andrew G. Farr7, Raphael Kopan1,2*
1 Department of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri, United States of America, 2 Division of Dermatology, Washington
University School of Medicine, St. Louis, Missouri, United States of America, 3 Renal Division, Department of Medicine, Washington University School of Medicine, St. Louis,
Missouri, United States of America, 4 Genome Sequencing Center, Washington University School of Medicine, St. Louis, Missouri, United States of America, 5 Rosetta
Inpharmatics, Seattle, Washington, United States of America, 6 Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, United
States of America, 7 Department of Biological Structure and Department of Immunology, University of Washington, Seattle, Washington, United States of America

Epidermal keratinocytes form a highly organized stratified epithelium and sustain a competent barrier function
together with dermal and hematopoietic cells. The Notch signaling pathway is a critical regulator of epidermal
integrity. Here, we show that keratinocyte-specific deletion of total Notch signaling triggered a severe systemic Blymphoproliferative disorder, causing death. RBP-j is the DNA binding partner of Notch, but both RBP-j–dependent and
independent Notch signaling were necessary for proper epidermal differentiation and lipid deposition. Loss of both
pathways caused a persistent defect in skin differentiation/barrier formation. In response, high levels of thymic
stromal lymphopoietin (TSLP) were released into systemic circulation by Notch-deficient keratinocytes that failed to
differentiate, starting in utero. Exposure to high TSLP levels during neonatal hematopoiesis resulted in drastic
expansion of peripheral pre- and immature B-lymphocytes, causing B-lymphoproliferative disorder associated with
major organ infiltration and subsequent death, a previously unappreciated systemic effect of TSLP. These observations
demonstrate that local skin perturbations can drive a lethal systemic disease and have important implications for a
wide range of humoral and autoimmune diseases with skin manifestations.
Citation: Demehri S, Liu Z, Lee J, Lin M-H, Crosby SD, et al. (2008) Notch-deficient skin induces a lethal systemic B-lymphoproliferative disorder by secreting TSLP, a sentinel
for epidermal integrity. PLoS Biol 6(5): e123. doi:10.1371/journal.pbio.0060123

cytes is consistent with its proposed role in suppressing basal
cell proliferation and promoting spinous cell differentiation
via cell autonomous modulation of targets [6–11]. However,
overexpression of activated Notch1 in the differentiated
spinous cells (where it is normally present) triggers basal cell
hyperproliferation and formation of acanthotic epidermis
with a thickened granular layer [12], indicating that the Notch
signaling pathway has a complex role by not only promoting
differentiation and exit from the basal layer but also by
contributing in a non-cell autonomous fashion to skin
homeostasis [12,13]. How Notch performs its functions within
spinous cells is a matter of some controversy, and multiple

Introduction
The vertebrate skin is an organ in which keratinocytes,
underlying mesenchymal cells, and circulating hematopoietic
cells engage in reciprocal communication as they monitor
organ integrity [1]. Therefore, skin is an ideal system in which
to study how complex, multicompartmental networks function. Epidermal keratinocytes are organized in several
distinct layers with the innermost (basal) layer containing
the stem cells and transiently amplifying cells [2]. The next
layer contains spinous cells that, under normal conditions,
begin a terminal differentiation program, giving rise to
granular and corniﬁed layers [3,4]. However, after injury,
spinous cells proliferate to contribute to the restoration of an
intact integument and produce cytokines that trigger an
inﬂammatory response [1]. Defects in execution of this
terminal differentiation program can lead to what are
collectively known as skin-barrier defects [5].
Notch activation contributes to spinous cell differentiation. Loss of canonical Notch signaling, induced by deletion
of the RBPSUH gene (coding for RBP-j, the DNA binding
partner of Notch), causes severe epidermal barrier and
differentiation defects highlighted by reduced spinous,
granular, and corniﬁed layer cells [6]. However, overexpression of activated Notch1 exclusively in basal cells under the
K14 promoter triggers their premature differentiation into
spinous cells, concomitant with loss of proliferative capacity
[6]. The pattern of Notch1 activation in epidermal keratinoPLoS Biology | www.plosbiology.org
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Author Summary

Results
Mice Lacking c-Secretase or All Notch Proteins in the Skin
Develop Severe B-LPD after Birth

Skin is the largest organ of the body, forming an elaborate barrier
that prevents water loss and protects the internal environment from
outside invaders. When this barrier is compromised, keratinocytes,
keratin-producing epidermal cells, alert and recruit the immune cells
to the site of the breach as part of an adaptive defense mechanism.
However, chronic activation of such an ‘‘alarm’’ could have
undesired consequences. Using genetic engineering to progressively remove components of Notch signaling from mouse skin in
utero resulted in chronic skin-barrier defects, mimicking a form of
human skin disease called atopic dermatitis. Surprisingly, we
discovered that a persistent alarm signal in newborns triggered a
systemic B-lymphoproliferative disorder, which precisely mirrored
the degree of skin defect and was lethal in its extreme form. This
alarm signal, in the form of a cytokine called thymic stromal
lymphopoietin, was produced by Notch-deficient keratinocytes that
failed to form a competent skin barrier. Therefore, we uncovered a
long-range proliferative effect on fetal pre-B cells in vivo that is
induced by injured skin and mediated by thymic stromal
lymphopoietin. These findings highlight the central role that skinderived factors can play in initiating systemic diseases with skin
involvement.

Removal of total Notch signaling from the skin using Msx2Cre led to death at weaning (Figure 1B; see [14]). To identify
the cause of death in Msx2-Cre/þ; N1 ﬂox/ﬂox ; N2 ﬂox/ﬂox
(N1N2CKO) and Msx2-Cre/þ; PS1ﬂox/ﬂox; PS2–/– (PSDCKO) mice,
a comprehensive necropsy was performed on the moribund
animals. Surprisingly, we found that mice from both
genotypes had extremely high white blood cell (WBC) counts
(.150,000 cells/ll) at around the time of death (Figure 1C).
Importantly, analysis of an extensive Notch allelic series
revealed that the severity of the leukocytosis during the ﬁrst
few weeks of life was correlated inversely with Notch dosage
(Figure 1C).
To characterize the cells causing leukocytosis, we analyzed
various hematopoietic parameters in Notch-deﬁcient mice.
Peripheral blood analysis showed that the leukocytosis in
both N1N2CKO and PSDCKO animals was of a lymphoblastic/lymphocytic nature; hence the mice displayed a severe
case of lymphoproliferative disorder (LPD; Figure 2A). This
LPD was accompanied by the failure of bone marrow (BM) to
participate in normal hematopoiesis, as demonstrated by
reduced red blood cells and platelets (normocytic anemia and
thrombocytopenia; Figure 2A). Because the blood phenotypes
of N1N2CKO and PSDCKO mice were similar, we use the
term ‘‘mutant’’ to describe the common LPD features of both
genotypes and ‘‘wild type’’ for all genetic combinations that
either lack Cre or carry Msx2-Cre and a wild-type allele of PS1.
Macroscopic examination showed that mutant mice were
smaller than their wild-type littermates and had enlarged
spleen and lymph nodes but smaller than normal thymus,
suggesting that the expanding lymphocytes are of B cell
origin (Figure 2B and Table S1). Flow cytometry (FC) analysis
on blood from mutant animals conﬁrmed that the expanding
population contributing to LPD was of the B cell lineage (BLPD; Figure 2C). These observations suggested that extreme
B-LPD could be the cause of death in PSDCKO and
N1N2CKO animals.

autonomous mechanisms have been proposed, including both
canonical and noncanonical pathways [6–11].
To study the role of Notch signaling in skin homeostasis
and barrier formation, we used the Msx2-Cre line to delete
components of the Notch signaling pathway in skin keratinocytes [14]. A burst of Msx2-Cre expression on embryonic
day 9.5 (E9.5) creates chimeric skin with dorsal and ventral
patches (clones) lacking ﬂoxed alleles, conﬁning the consequences of gene loss only to a fraction of the surface area
(for a detailed analysis of Msx2-Cre expression in skin, see
[14,15]). This allows animals lacking total Notch signaling to
survive through birth (Figure 1A). With this system, we have
shown previously that Notch loss also involves non-cell
autonomous alteration in transforming growth factor ß and
insulin-like growth factor signaling [15]. Removal of both
Notch1 and Notch2 proteins or both presenilin-1 (PS1) and
presenilin-2 (PS2) proteins (the catalytic subunits of csecretase) within epidermal clones is sufﬁcient to cause early
postnatal lethality [14]. In the current study, we investigated
the mechanistic basis for this early demise.
The progressive loss of Notch alleles in skin keratinocytes
generated a dose-dependent increase in thymic stromal
lymphopoietin (TSLP) expression by suprabasal keratinocytes
in direct response to defective skin differentiation/barrier
formation in utero. TSLP is a recently discovered, epidermally derived cytokine implicated in the pathogenesis of
atopic dermatitis and asthma [16]. Like interleukin 7 (IL-7),
TSLP can support B cell development; however, the in vivo
effects of high TSLP levels on B-lymphopoiesis are not fully
understood [17]. A perinatal increase in TSLP levels
produced a dose-dependent expansion of pre- and immature B cells in the periphery, causing a B-lymphoproliferative disorder (B-LPD), a previously unappreciated effect of
TSLP. In its extreme form, B-LPD complications, including
B cell inﬁltration into vital organs, culminated in death.
Therefore, this study provides the ﬁrst physiological conﬁrmation that skin perturbation can cause a lethal systemic
disease.
PLoS Biology | www.plosbiology.org

RBP-j–Independent (but c-Secretase–Dependent) Notch
Signaling in the Skin Contributes to Longevity
Unexpectedly, Msx2-Cre/þ; RBP-j ﬂox/ﬂox (RBP-jCKO) mice
lived signiﬁcantly longer (95 days on average) and showed
lower WBC counts (;70,000 cells/ll) compared to mice
lacking Notch receptors or c-secretase (Figure 1B and 1C).
Although we could not exclude the possibility that Cremediated deletion of RBPSUH is marginally less efﬁcient than
that of PS1 or Notch1 and Notch2, examination of RBP-j
protein in RBP-jCKO animals conﬁrmed its loss in keratinocytes (Figure S1). If RBP-j could actively repress some target
genes in the absence of Notch signaling and this repression
would be lost upon RBP-j deletion, then the milder RBP-j
phenotype could be explained by de-repression of some
targets that ameliorated the phenotype [18]. Alternatively, the
Notch pathway may have bifurcated; RBP-j-independent (yet
c-secretase-dependent) targets of Notch in skin [10,19] may
contribute to the severity of the phenotypes reported here.
To distinguish between these possibilities, mice that lack both
c-secretase and RBP-j in the skin were generated (Msx2-Cre/þ;
PS1ﬂox/ﬂox; PS2–/–; RBP-j ﬂox/ﬂox; PSDRBP-jCKO). In this genetic
0993
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those. Abbreviations: wild type (Wt), Msx2-Cre/þ; N1flox/flox (N1CKO),
Msx2-Cre/þ; N1flox/flox; N2flox/þ (N1N2hCKO), Msx2-Cre/þ; N1flox/flox; N2flox/þ;
N3–/– (N1N2hN3CKO), Msx2-Cre/þ; N1flox/flox; N2flox/flox (N1N2CKO),
PSDCKO, Msx2-Cre/þ; RBP-jflox/flox (RBP-jCKO), Msx2-Cre/þ; PS1flox/flox;
PS2–/–; RBP-jflox/flox; (PSDRBP-jCKO), and Msx2-Cre/þ; N1flox/flox; N2flox/flox;
RBP-jflox/flox (N1N2RBP-jCKO). Note that N1N2CKO, PSDCKO, PSDRBPjCKO, and N1N2RBP-jCKO animals live only a few weeks and experience
severe leukocytosis. Data are collected from lifelong monitoring of 10 to
20 animals from each genotype. Significant difference (p , 0.05)
between adjacent genotypes is highlighted by an asterisk.
doi:10.1371/journal.pbio.0060123.g001

experiment, de-repressed targets should suppress the
PSDCKO phenotype (i.e., PSDRBP-jCKO would display the
RBP-jCKO phenotype [18]). However, if RBP-j-independent
targets of Notch contribute to the life span and leukocytosis,
then the c-secretase mutation should be epistatic to RBP-j
(i.e., the animal will have the PSDCKO phenotype). A
combination of both would be expected to produce an
intermediate phenotype.
The PSDRBP-jCKO mice lost RBP-j yet had the same life
expectancy as PSDCKO mice (Figure 1B) and had WBC
counts comparable to those of PSDCKO (Figure 1C), a result
inconsistent with target de-repression. To conﬁrm that these
outcomes were Notch-dependent but RBP-j-independent, we
also created the triple mutant Msx2-Cre/þ; N1 ﬂox/ﬂox; N2 ﬂox/ﬂox;
RBP-j ﬂox/ﬂox (N1N2RBP-jCKO). As with PSDRBP-jCKO animals, the life span of N1N2RBP-jCKO animals was not
prolonged by removal of RBP-j (Figure 1B and 1C), indicating
that a Notch-dependent activity contributes to the phenotype. This suggested that canonical Notch signaling could not
be the sole determinant of the phenotypes described and
instead supports the alternative assertion that RBP-j-independent effects of Notch in the skin may contribute to
leukocytosis [10,20]. This result provides the ﬁrst genetic
evidence in a vertebrate to support the existence of a
bifurcation in Notch signaling downstream of c-secretase.

Drastic but Transient Expansion of B-Lymphocytes Results
in Severe Systemic Complications in Notch-Deficient
Animals
To understand B-LPD progression better, the WBC count
from mutant animals was measured over their life span
(Figure 2D). The WBC counts increased exponentially over
the ﬁrst 2 weeks starting at around P4 but plateaued during
the third week of life within the same time window when most
mutant animals expired. However, to our surprise, the longest
surviving mice showed a trend toward normalization of their
WBC counts (Figure 2D). A reduction in peripheral B cell
number (and thus normalization of WBC count) was more
evident in animals with partial loss of Notch signaling and in
the longer living RBP-jCKO mice (unpublished data).
Accompanying the surge in peripheral WBC count, B220þ B
cells expanded the spleen (splenomegaly) and inﬁltrated
several vital organs including lung and liver (Figure 2E, 2F,
and Figure S2A). To characterize the identity of the
expanding cells in B-LPD further, two additional markers,
CD43 and IgM, were applied to segregate pro-, pre-, and
immature B cell populations by FC (Figure 3A). The FC
analysis showed that pre-B cells (B220þCD43–IgM–) constituted the majority of the expanding population in both BM
and periphery (Figure 3B, red ovals). Immature B cells also
expanded, as would be expected if differentiation of pre- to
immature B cells persisted in the mutant animals (Figure 3B).

Figure 1. Notch Dosage in the Skin, the Animals’ Life Span, and WBC
Count Are Tightly Correlated
(A) Chimeric pattern of Msx2-Cre activity is shown on the left by X-gal
staining of an E15.5 Msx2-Cre/þ; Rosa26R/þ embryo (also see [14,15]). On
the right, the dorsal patch of hair loss in P9 Msx2-Cre/þ; PS1flox/flox; PS2–/–
(PSDCKO) mice (border is highlighted by red broken line) matches the
area of Cre activity.
Progressive (B) shortening of life span and (C) increase in peak WBC
count measured during the second week of life are caused by stepwise
removal of Notch proteins, RBP-j, Presenilins, or certain combinations of
PLoS Biology | www.plosbiology.org
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Figure 2. Mice Lacking Total Notch Signaling in the Skin Develop Severe B-LPD
(A) Table shows the peripheral blood analysis of the mutant mice during the second week of life when WBC counts are at their maximum (n ¼ 6, for each
group). The values are presented as mean 6 standard deviation (‘‘a’’ indicates p , 0.001 and ‘‘b’’ indicates p , 0.05 (compared to wild-type control)).
(B) Macroscopic examination of a P14 mutant (N1N2CKO) compared to its wild-type littermate reveals the mutant’s smaller body size yet significantly
larger spleen and lymph nodes.
(C) Peripheral blood smear (Giemsa-stained; 2503 magnification) and FC analysis show the appearance of lymphoblasts (inset) and the expansion of
B220þ B cells in the mutant blood, respectively.
(D) Monitoring the mutant animals’ WBC counts over their life span (n ¼ 10 for each genotype) demonstrates a surge during the first 2 weeks and plateau
during the third week of life, when most mutants die (asterisk). Note the trend of WBC counts toward normalization in a few mice that live a few days longer.
Severe B-LPD leads to infiltration of liver, lung, and spleen of the mutant animals with B220þ B cells shown on (E) hematoxylin-and-eosin-stained tissue
sections and (F) antibody-stained liver sections (2003 magnification).
doi:10.1371/journal.pbio.0060123.g002
PLoS Biology | www.plosbiology.org
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that failed to thrive during the early stages of postnatal
development.

Blocking B-LPD Prevents Early Lethality in the Mutant
Mice
To determine whether B-LPD was an important contributor to early death, we performed an allogeneic bone marrow
transplantation (BMT) experiment with mutant animals as
the recipients. Lethally irradiated mutant mice transplanted
with BM derived from their wild-type littermates around
postnatal day 10 (P10) lived signiﬁcantly longer than their
untransplanted counterparts (Figure 4A). However, the
transplanted mutants still died within a few weeks after
transplantation, this time because of severe skin phenotypes
including exfoliation, bleeding, inﬂammation, and infection
(Figure S2C). When treated with systemic antibiotics, the life
span of transplanted N1N2CKO animals was extended
further and became comparable to that of RBP-jCKO mice
(Figures 4A and 1B). However, antibiotic treatment of
PSDCKO mice did not extend further their life span due to
the greater severity of skin disease in these animals (Figure
S2C). The WBC counts and FC analyses showed no reoccurrence of B-LPD in the transplanted mutants (Figure 4B and
4C). However, a signiﬁcant expansion of granulocytes/monocytes was observed in the peripheral blood of transplanted
mutant animals during the ﬁnal days of life with WBC counts
reaching ;20,000 cells/ll (Figure 4B, 4C, and Figure S3).
Similar granulocytosis accompanied by elevated peripheral
T-lymphocyte percentage was observed in RBP-jCKO mice of
the same age (Figure S3).
The observations detailed above suggested that if B-LPD
was controlled, then life expectancy of the mutant animals
could be increased signiﬁcantly. Indeed, either a sublethal
dose of total body irradiation (;450 cGy) or focal irradiation
of the mutant animals extended their life span. In both cases,
life expansion correlated with a delay in B-LPD surge (Figure
S4). Taken together, these experiments strongly demonstrated that B-LPD, acquired by animals with Notch- or csecretase-deﬁcient skin, was a critical mediator of early
lethality. However, the short life expectancy of transplanted
mutants and RBP-jCKO was related to their skin disease,
infection, and granulocyte/monocyte expansion, which again
occurred in a Notch dose-dependent manner and in all adult
animals lacking canonical Notch signaling (unpublished data
and Dr. Freddy Radtke, personal communication).

Figure 3. Expanding Pre- and Immature B Cells Cause B-LPD in the
Mutant Animals
(A) Schematic representation of how surface markers applied (B220,
CD43, and IgM) identify pro-, pre-, and immature B cells.
(B) FC analyses of BM and spleen cells demonstrate a clear expansion of
pre- (red circle) and immature (blue circle) B cells in both central and
peripheral compartments of the mutant animals. More than three mice
from each genotype (PSDCKO, N1N2CKO, and wild-type littermates) are
analyzed. Representative plots are shown.
doi:10.1371/journal.pbio.0060123.g003

B-LPD Is a Non-Autonomous Consequence of Losing
Notch or c-Secretase in Skin Keratinocytes
Considering the importance of Notch signaling at various
stages of lymphopoiesis [22,23] and the potential for ectopic
expression of Msx2-Cre in a hematopoietic organ, we asked
whether deletion of Notch in BM or any hematopoietic organ
might have caused B-LPD. To map the sites of Msx2-Cre
activity thoroughly, we applied the following approaches.
First, using a PCR protocol designed to detect the deleted
allele of PS1 (PS1D), we conﬁrmed that neither hematopoietic
cells nor any hematopoiesis-related organ experienced Cremediated deletion of PS1 in PSDCKO mice (Figure 4D). Of
note, we collected peripheral blood from the mutant animals
at peak WBC counts, which thus was composed mostly
(.90%) of expanding B cells, but still found no evidence of
PS1 deletion. To rule out the possibility that loss of Notch

The ability of pre-B cells to differentiate and the high WBC
counts reached at an early age are consistent with a
polyclonal origin of this B-LPD [21]. Large expansion of
immature B cells was associated with elevated IgM levels,
which precipitated at low temperature, a condition known as
cryoglobulinemia (Figure S2B). Overall, despite the short
duration of B-LPD in Notch-deﬁcient mice, we hypothesized
that extremely high WBC count, leukostasis, cryoglobulinemia, anemia, and inﬁltration of B cells into vital organs
conspired with the skin phenotype to produce cachexic mice
PLoS Biology | www.plosbiology.org
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Figure 4. BMT Cures the Lethal B-LPD in the Mutant Animals and Confirms the Local Deletion of Notch Pathway in the Skin as the Sole Driver of B-LPD
(A) Both PSDCKO and N1N2CKO mice, lethally irradiated and transplanted with BM from their wild-type (n ¼ 4) or mutant (n ¼ 3) littermates (at ;P10),
live significantly longer than their untransplanted mutant counterparts (n ¼ 20; p , 0.001, log rank test). In the N1N2CKO group, three mice that are
transplanted with wild-type BM also receive daily antibiotic treatment after BMT, leading to their significantly longer life span compared to other
transplanted mutants (p , 0.001, log rank test). B-LPD does not recur in the transplanted mutant animals shown by (B) their persistently low WBC count
during their post-BMT life (data are drawn from four animals in each genetic group) and (C) on average lower B220þ B cell percentage in their blood as
compared to the wild-type recipients, measured 25 d after transplantation (four PSDCKO and four wild-type littermates are compared). Note that at this
stage the transplanted PSDCKO animals develop granulocytosis with significantly higher granulocyte/monocyte percentage (*, p , 0.05).
(D) Msx2-Cre-mediated PS1 gene deletion (PS1D) is only detectable in the skin of the PSDCKO animals. The data are representative of three independent
tests. DNA samples are prepared from PSDCKO animals with WBC count .100,000 cells/ll. BM samples are unfractionated and include BM stroma.
(E) Wild-type mice (;P10) receiving BMT from their mutant (n ¼ 12, both N1N2CKO and PSDCKO are included) or wild-type (n ¼ 12) littermates
reconstitute normal hematopoiesis and have a normal life span without developing B-LPD.
doi:10.1371/journal.pbio.0060123.g004

munodeﬁciency (NOD/SCID) mice were indistinguishable in
their ability to rescue the recipients (Figure S6). Collectively,
these ﬁndings conﬁrmed the non-autonomous nature of BLPD and implicated the skin as the primary organ responsible
for the disease in Notch/c-secretase-deﬁcient animals.

signaling in a small subset of BM stromal cells could drive B
cell expansion in the mutant animals, we re-analyzed Prx1Cre; PS1ﬂox/ﬂox; PS2–/– mice in which Cre is active in BM stroma,
the osteoblasts [24,25], and the osteoclasts [26]. The WBC
analysis in all these mice showed no sign of B cell expansion
(unpublished data), indicating that another organ provided
the trigger for B-LPD. Next, we analyzed two reporter lines,
Msx2-Cre; ZEG/þ and Msx2-Cre; Rosa26R/þ. Only the skin was
marked by these reporters (unpublished data) with no
detectable reporter staining in any hematopoietic lineage
or organ. Together, these ﬁndings led us to hypothesize that
B-LPD was driven non-autonomously in wild-type B cells as a
consequence of reduced Notch signaling in the skin.
To test this hypothesis, we applied the allogeneic BMT
paradigm to ask whether hematopoietic stem cells isolated
from the mutant animals could propagate B-LPD in normal
recipients. The BM derived from mutant or wild-type
littermates was equally competent in its ability to engraft in
lethally irradiated wild-type littermate hosts and reconstitute
a complete hematopoietic system that sustained a normal
WBC count in the recipient animals over several months of
follow-up (Figure 4E). The PCR analysis conﬁrmed the
complete repopulation of the recipients’ hematopoietic
system by donor-derived BM (Figure S5B). In addition, BM
transplanted from mutant or wild-type animals into sublethally irradiated nonobese diabetic/severe combined imPLoS Biology | www.plosbiology.org

High Levels of TSLP Strongly Correlate with the Intensity
and Timing of B-LPD in Notch-Deficient Animals
Having identiﬁed skin keratinocytes as the only cells in
which Cre-mediated deletion of Notch signaling was occurring, we hypothesized the existence of (an) epidermally
derived cytokine(s) capable of driving B cell expansion that
accumulated to high systemic levels in inverse correlation
with Notch dose. To search for such factor(s), we performed
microarray analysis of mutant and wild-type total-skin RNA
samples collected at P9. Given the dose–response observed
with life expectancy and B-LPD, we performed a modiﬁed
trend analysis asking for transcripts that were modestly
elevated in Notch1-deﬁcient (N1CKO) skin but substantially
elevated in N1N2CKO or PSDCKO skin. A small subset of
altered transcripts, highly enriched for chemokines and
chemoattractants, displayed the desired trend (Figures 5A
and S7 and Table S2). Among them, TSLP was the second
most abundant transcript and the only epidermally derived
cytokine capable of driving fetal B cell proliferation in mouse
[17,27].
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immune signature that could provide an alternative mechanism for B-LPD in the mutant mice (Table S3), including IL-7,
the main cytokine implicated in B cell development.
Interleukin 6 (IL-6), the only other cytokine implicated in
B-lymphopoiesis, which showed moderate yet signiﬁcant upregulation in the skin microarray trend analysis, was elevated
,2-fold in serum (Figure 5C). Examination of the sera from
entire allelic series of Notch-deﬁcient mice by ELISA
conﬁrmed and extended our trend analysis: The TSLP levels
showed a strong inverse correlation with the dose of Notch
signaling and life expectancy (Figure 5D) and a direct
correlation with WBC counts of the mutant animals (Figures
1B, 1C, 5D, and Figure S9).

Increasing TSLP Levels Is Sufficient To Cause B-LPD in Mice
but Only during the First Weeks of Life
Collectively, RNA and protein analyses created a consistent
picture pointing to TSLP as the likely candidate satisfying
most of the criteria for the B-LPD-inducing agent: sensitivity
to reduction in Notch dose, systemic availability, and the
ability to promote B cell development [17,27]. However, such
a proliferative role for TSLP has not been demonstrated
previously. To satisfy Koch’s postulate for disease causation,
we injected recombinant mouse TSLP into wild-type mice.
Daily injection of the animals with TSLP starting at birth and
continuing for 7 days led to a dose-dependent elevation of
WBC count (Figure 6A). The FC analysis on peripheral blood
from the mice injected with TSLP identiﬁed the expanding
cell population as B220þ B-lymphocytes, not seen in mice
receiving carrier alone (Figure 6B). Further analysis of
peripheral blood from wild-type mice receiving 1 lg of TSLP
identiﬁed the expanding B cell population as pre- and
immature B cells (Figure 6C). Injecting wild-type animals with
1 lg of TSLP daily resulted in steady-state serum TSLP levels
of ;250 pg/ml, comparable to that in N1CKO animals
(Figures 6A, 5D, and Figure S9). Likewise, WBC counts in
these animals were also indistinguishable from those seen in
N1CKO mice at P8 (Figures 6A, 1C, and Figure S9). Thus,
elevated TSLP levels were sufﬁcient to cause mild B-LPD in
an otherwise normal newborn mouse. Signiﬁcantly and in
agreement with published reports, no surge in WBC count
was detected when the treatment regimen was initiated at P14
or later (Figure 6A; [28,29]). To demonstrate a correlation
between endogenous levels of TSLP and high WBC counts, we
analyzed K14-TSLPtg transgenic mice [30]. This analysis
revealed high serum TSLP levels of ;3 ng/ml in K14-TSLPtg
newborns and, as predicted by our hypothesis, neonatal BLPD similar to that observed in RBP-j-deﬁcient animals
(Figure 6D–G and S9). Importantly, B-LPD in K14-TSLPtg
newborns developed in the absence of any overt skin
morphology (unpublished data), indicating that elevated
TSLP is not impeding epidermal differentiation. Consistent
with the ﬁndings above, K14-TSLPtg animals also developed BLPD only during the neonatal period, which disappeared
later in life despite elevated serum TSLP levels (Figure 6D and
6E). This experiment conﬁrmed that TSLP overexpression
after the neonatal period did not sustain B-LPD in mice.
To ask if B-LPD represented the conﬂuence of high TSLP
with a responding, fetal pre-B cell population, we performed
fetal liver transplantation (FLT) into lethally irradiated
mutant animals. Surprisingly, FLT reconstituted normal adult
hematopoiesis in the recipients, suggesting that fetal pre-B

Figure 5. TSLP Is Highly Expressed in the Skin Lacking Total Notch
Signaling, Leading to Its High Systemic Levels
Such elevated serum levels inversely correlate with Notch dosage in the
skin.
(A) Modified trend analysis performed on microarray data from P9
mutant and wild-type total-skin RNA samples identifies TSLP as the most
up-regulated cytokine gene in the mutants. The epidermal overexpression of TSLP in the mutant mice is confirmed by qRT-PCR.
(B) TSLP is mainly produced by suprabasal keratinocytes in the mutant
epidermis (2003 magnification).
(C) Unlike IL-6 and IL-7, TSLP serum protein levels measured on ELISA are
highly elevated in the mutant animals.
(D) Serum analyses during the second week of life show that TSLP levels
increase as more alleles of Notch are removed from the skin. Data are
extracted from comparing three mutant (of each genotype) and three
wild-type littermates (*, p , 0.05, **, p , 0.01, ***, p , 0.0001).
doi:10.1371/journal.pbio.0060123.g005

Quantitative reverse transcription PCR (qRT-PCR) on
epidermal mRNA samples conﬁrmed a ;20-fold increase of
TSLP mRNA in mutants (Figure 5A and Table S2), and
immunohistochemical analysis on skin sections identiﬁed
suprabasal keratinocytes as the source of TSLP (Figure 5B
and Figure S8). ELISA measurements detected TSLP levels
.5000-fold above the normal levels in sera from mutant mice
(;50 ng/ml versus ,10 pg/ml) that were already detectable at
birth (unpublished data). A comprehensive serum analysis
failed to detect differences in any other cytokine or autoPLoS Biology | www.plosbiology.org
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Figure 6. TSLP Is Sufficient To Drive B-LPD in Newborn Animals
(A) Wild-type mice injected intravascularly with carrier alone (PBS), 0.5, 1, or 1.5 lg of recombinant mouse TSLP daily for 7 days show a dose-dependent
increase in serum TSLP levels and WBC counts (measured 12 h after the last dosing) only if the treatment starts at P0. The impact of elevated serum
TSLP on WBC count is diminished or absent when the treatment starts on P7 or P14, respectively (n ¼ 3, for each condition; *, p , 0.05 and **, p , 0.01).
(B and C) FC analysis on peripheral blood from mice receiving 1 lg of TSLP daily for 7 days starting at P0 confirms that the increase in WBC count is
because of the expansion of pre- (red circles) and immature B cells in the periphery, identical to N1CKO newborns that have similar serum TSLP levels
and WBC counts (n ¼ 3, for each group; *, p , 0.05).
(D) K14-TSLPtg mice phenocopy the neonatal B-LPD in RBP-jCKO animals; they have highly elevated serum TSLP levels at several time points during the
first two weeks of life (averaged as pup). Adult animals (.P21) also have elevated TSLP in their serum but to a lesser degree than in the pups.
(E and F) In addition, K14-TSLPtg mice have high WBC counts due to B-LPD during the first few weeks of life (*, p , 0.05).
(G) FC analysis identifies the expanding population of cells causing B-LPD as pre- (red circle) and immature B cells. TSLP measurements and FC analyses
are performed on three K14-TSLPtg mice and three wild-type littermates. WBC counts are obtained from six mice in each group.
doi:10.1371/journal.pbio.0060123.g006

which B-LPD can develop (Figure 4A). These results conﬁrmed that B-LPD developed as a result of exposure to high
TSLP levels in the perinatal period.

cells in an adult niche microenvironment lost their ability to
respond to high levels of TSLP (Figure S10). To ask if
continuous exposure to high TSLP levels sustained a
responding pre-B cell population, we performed a third
allogeneic BMT experiment in which BM from the mutant
animals was transplanted into their lethally irradiated mutant
littermates (which continued to produce high TSLP levels,
unpublished data). Again, the donor-derived BM reconstituted normal adult hematopoiesis in the recipients, curing
their B-LPD, consistent with the limited temporal window in
PLoS Biology | www.plosbiology.org

TSLP Overproduction Is a General Response to Structural
Abnormalities in Notch-Deficient Skin before Birth
Loss of Notch signaling in skin keratinocytes leads to
elevated epidermal TSLP production and high serum TSLP
levels, reaching a maximum only when all Notch proteins or
c-secretase are removed (Figure 5). The TSLP overexpression
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Figure 7. Skin-Barrier Defect Explains How Loss of Notch Signaling in the Skin Leads to Elevated TSLP Production
(A) P0 PSDCKO dorsal skin shows a severe epidermal differentiation defect (loss of spinous and granular layers) compared to wild-type littermate (2003
magnification).
(B) Heat map of microarray data on P9 epidermal RNA shows down-regulation (green) of genes involved in epidermal lipid biogenesis in the mutants
versus their wild-type littermates. Note that TSLP probes are included as a control.
(C) The Nile Red florescent staining of the polar (red) and non-polar (green) lipids in the epidermis of a P5 PSDCKO mouse demonstrates a deficient lipid
coat in c-secretase-deficient (mutant) versus unaffected areas (wild type) of the epidermis [48]. Note the prominent green florescent staining of the
sebaceous gland in the wild-type section (arrow), which is absent in the skin lacking Notch signaling [14].
(D) The dye penetration assay shows a defect in the skin barrier of the mutant animal at E18.5.
(E) Keratinocytes cultured from the mutant (PSDCKO) or wild-type littermates in the presence or absence of calcium release similar yet significant
amounts of TSLP into their medium. However, keratinocyte TSLP production decreases by inhibiting NFjB signaling (BAY 11–7082: 2.5, 5, 10 lM; *: p ,
0.01) in a dose-dependent manner (data are accumulated from three independent experiments; TSLP levels are presented relative to that of wild-type
cells in the absence of calcium and inhibitor). The immunoblot panel confirms that the mutant keratinocyte are deficient in PS1 protein.
(F) The wrfr–/– embryos show a surge in the skin TSLP expression around the time of skin-barrier formation, as detected by microarray. Note that known
Notch targets, Hes and Hey proteins, are not altered in wrfr–/– mice. TSLP up-regulation translates into its highly elevated serum levels in wrfr–/– mice at
birth (n ¼ 3; p , 0.0001).
doi:10.1371/journal.pbio.0060123.g007

thus may be a general response of epidermal keratinocytes to
differentiation (and skin-barrier) defect [5]. Notch-deﬁcient
epidermis was defective in epidermal differentiation, leading
to incomplete formation of upper spinous and granular
PLoS Biology | www.plosbiology.org

layers, as reported in RBP-j-deﬁcient animals (Figure 7A; [6]).
This was accompanied by global down-regulation of skin lipid
biosynthetic enzymes and reduced epidermal lipid content
(Figure 7B and 7C and Table S4). Consequently, a defect in
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of failed differentiation and not a speciﬁc repressed target of
Notch signaling, we analyzed wrfr–/– mice that lack fatty acid
transport protein 4 (FATP4) and die at birth because of
severe epidermal differentiation and skin-barrier defects [34].
As in Notch-deﬁcient mice, B-LPD was not yet detectable in
wrfr–/– mice at birth. These mice, however, did show a
substantial surge in skin TSLP transcript levels around the
time of stratiﬁcation and barrier formation (E15.5–17.5),
which led to elevated serum TSLP levels at birth (Figure 7F).
Because FATP4 expression is not altered in Notch-deﬁcient
skin (unpublished data) and Notch pathway targets are not
altered in wrfr–/– skin (Figure 7F), this observation provided
an independent conﬁrmation that up-regulation of TSLP
expression is a common readout of differentiation/barrier
formation defects and not a repressed target of Notch
signaling.

Discussion
Skin-Specific Deletion of Notch Signaling Leads to a Lethal
B-LPD
This report details the mechanism by which a local
perturbation to the skin induced a lethal systemic disease.
We demonstrate that progressive loss of Notch signaling in
the embryonic ectoderm caused a dose-dependent impairment of epidermal differentiation and reduced lipid biogenesis, stimulating keratinocytes to secrete excess TSLP into
systemic circulation. The pathophysiological consequence of
persistent differentiation/barrier defects and the subsequent
accumulation of TSLP had a potent proliferative effect on
fetal/newborn B-lymphopoiesis, causing an exceptional expansion of pre- and immature B cell populations in newborn
animals (i.e., neonatal B-LPD; Figure 8). A severe B-LPD with
its systemic complications including inﬁltration of B cells into
various vital organs, anemia, and cryoglobulinemia explained
the early death of the animals lacking total (canonical and
noncanonical) Notch signaling in the skin. Indeed, we were
able to extend the life span of the mutant newborn animals
simply by suppressing their B-LPD through either BMT or
sublethal or focal irradiation administered before the onset
of full-blown B-LPD in the second week of life. The
ameliorating effects of these treatments also reﬂect the fact
that pre-B cells emerging in the adult BM niche are refractory
to high TSLP levels (see below).

Figure 8. Model of the Role of the Notch Signaling Pathway in Setting up
Competent Skin Barrier and Preventing B-LPD in Newborn Animals
RBP-j-dependent and independent Notch signaling is required for proper
epidermal differentiation and lipid biogenesis in the skin to form a
competent barrier. The RBP-j-independent signals may be non-cell
autonomous. Embryonic loss of Notch signaling leads to aberrant
epidermal differentiation/lipid biogenesis and, therefore, the defective
barrier formation. In response, TSLP is released by keratinocytes that fail
to differentiate, triggering a systemic B-LPD in newborns that results in
neonatal lethality at the highest level.
doi:10.1371/journal.pbio.0060123.g008

skin-barrier function was detectable directly by using the dye
exclusion assay; this procedure stains areas with defective
barrier, and indeed, only the stereotypical pattern of Creexpression was stained in the mutant animals, consistent with
a barrier defect in c-secretase-deﬁcient keratinocytes (Figure
7D; [6]).
To further ascertain if TSLP overexpression is a consequence of Notch loss or a consequence of defective differentiation/barrier formation, we isolated keratinocytes from
mutant and wild-type pups and measured TSLP in the culture
medium of cells grown on plastic. Both mutant and wild-type
keratinocytes fail to form a fully differentiated epidermis
under these conditions, and both secreted similar and
signiﬁcant levels of TSLP, as would be expected if TSLP
overproduction was a general consequence of abnormal
keratinocyte differentiation and not a speciﬁc consequence
for loss of Notch signaling (Figure 7E). Because NFjB
signaling, a potent inducer of differentiation, can activate
TSLP [31,32], we asked if this pathway was responsible for
TSLP expression in cultured keratinocytes. Addition of an
inhibitor of NFjB signaling, BAY 11–7082 [33], abrogated
TSLP production in a dose-dependent manner in both wildtype and c-secretase-deﬁcient keratinocytes (Figure 7E). To
solidify the conclusion that TSLP overproduction is a readout
PLoS Biology | www.plosbiology.org

Novel Function of TSLP Explains the Main Features of BLPD in Notch-Deficient Newborns
A growing body of work has provided extensive evidence
that TSLP overexpression in skin or lung epithelia can cause
local allergic inﬂammation and subsequent development of
atopic dermatitis and asthma, respectively [16,35,36]. However, the systemic consequences of TSLP overexpression were
not clear [29,37]. In this report, we describe the mice in which
defects in skin differentiation drive endogenous TSLP
expression, beginning before birth. We ﬁnd that TSLP levels
are correlated directly with the degree of disruption in
differentiation. This enabled us to recognize a novel
consequence for TSLP elevation unique to fetal/newborn
hematopoiesis and to ascribe TSLP production to failure in
skin differentiation rather than its cause, as high levels of
TSLP did not alter skin differentiation in newborn K14TSLPtg mice.
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It has been recognized that TSLP has a differential effect
on fetal versus adult B-lymphopoiesis [27,38], despite the
presence of fully functional TSLP receptors on both fetal and
adult B cells [27,39]. In addition, in vitro results show that a
liver-derived fetal pre-B cell line, NAG8/7, but not a BMderived adult pre-B cell line, IxN/2B, proliferate in response
to TSLP [40]. Consistent with these ﬁndings, we demonstrate
that endogenously overexpressed or exogenously supplied
TSLP, delivered during the perinatal period, lead to B-LPD
and the appearance of a substantial number of pre-B cells
(B220þCD43–IgM–) in the periphery in a dose-dependent
manner (Figure S9). Transition from fetal/newborn to adult
hematopoiesis occurs during the second week of life in the
mouse BM [41]. We ﬁnd that persistently high levels of TSLP
do not produce B-LPD after this transition, explaining why BLPD has not been detected in previous studies [29,37]. The
narrow window in which TSLP can drive pre-B cell expansion
explains why B-LPD in Notch-deﬁcient and K14-TSLPtg
animals is (1) conﬁned to the ﬁrst few weeks of life, (2)
disappears in animals that experience a less severe disease,
and (3) does not recur in the mutant mice after BMT, because
adult-type pre-B cells that are reconstituted from the donor
BM do not proliferate in response to high TSLP levels [38]. In
addition, the fact that B-LPD does not recur in the mutant
mice after FLT is consistent with the hypothesis that the
niche is instrumental in regulating the response of pre-B cells
to TSLP. This is reminiscent of the critical role the
hematopoietic stem cell niche plays in deﬁning the fetal
versus adult characteristics of hematopoietic stem cells [42].

many insults, including Notch loss, activate. To conﬁrm this,
we demonstrate that wild-type and mutant keratinocytes
release signiﬁcant, but similar, levels of TSLP when placed in
culture in the absence of any exogenous stimulus (e.g., tumor
necrosis factor a). In addition, wrfr–/– embryos show a
substantial increase in epidermal TSLP transcripts in utero
around the time of barrier formation. Therefore, TSLP is a
keratinocyte ‘‘quality control’’ response to defective differentiation/barrier formation and not a secondary product of
functional barrier failure after birth. One model for how the
TSLP ‘‘sensor’’ works may be through the compensatory
activation of NFjB. However, precisely how Notch loss in vivo
leads to NFjB activation remains an important unanswered
question that falls beyond the scope of this paper.
A striking ﬁnding is that RBP-jCKO mice show lower TSLP
levels, a sublethal B-LPD, and improved epidermal morphology when compared to mice lacking total Notch signaling
(Figure S11). To differentiate between de-repression of
canonical targets and loss of noncanonical target expression,
we performed a genetic analysis demonstrating unequivocally
that RBP-j-independent Notch activity is of signiﬁcance in
skin homeostasis. This points to the importance of RBP-jindependent effects of Notch, including non-cell autonomous
effects on ligand (Delta and Jagged) presenting cells, and only
when all these arms of Notch signaling are lost, extreme TSLP
levels are reached, causing lethal B-LPD (Figure 8). Identiﬁcation of the relevant noncanonical targets also falls beyond
the scope of this paper.

Intrinsic Skin Phenotype and Infection Cause Death in
Adult Mice Lacking Canonical Notch Signaling

In this report, we identiﬁed canonical and noncanonical
Notch signaling as essential regulators of epidermal differentiation/barrier formation, TSLP as a faithful reporter of
keratinocyte differentiation/barrier defects, and B-LPD as the
pathological consequence of chronic, perinatal TSLP elevation. Our analysis was done in a physiologically relevant
setting: chronic skin-barrier formation defect caused by
localized reduction in Notch signaling in a temporal and
dose-dependent manner. How keratinocytes directly sense
the degree of differentiation/barrier defect and translate such
a stimulus into TSLP output remains an important, unsolved
question. Nonetheless, the demonstration that defective skin
differentiation can drive a lethal systemic B-LPD in mice
through TSLP overexpression and the observation that
human B cells also respond to TSLP [29] bring up a
therapeutically important possibility that chronic high levels
of TSLP may be an initiating factor in loss of B cell tolerance
and/or B-lymphocytosis, a leukemia-like disease in humans.
More important, this raises the possibility that skin has a
central role in driving a wide variety of inﬂammatory and
humoral diseases in which skin complications are also
present.

Conclusion

N1N2CKO or PSDCKO mutant animals transplanted with
either wild-type or mutant BM do not enjoy a normal life
span, dying before 3 months of age. Mice lacking some Notch
alleles or lacking RBP-j do not develop lethal B-LPD but
instead die prematurely from compromised skin integrity,
exfoliation, inﬂammation, and systemic infection (unpublished data). Although antibiotic treatment delays the death
of the mutant animals by controlling their infection, we ﬁnd
persistent granulocytosis even in antibiotic-treated mice,
suggesting that systemic infection and the resulting inﬂammatory response are severe and incurable. Infection is the
most likely cause of granulocytosis in the mutant animals;
however, it is intriguing to speculate that persistently high
levels of TSLP also contribute to this blood disease ([37] and
Dr. Freddy Radtke, personal communication).

TSLP Overexpression in Notch-Deficient Skin Is a Common
Keratinocyte Response to Skin-Barrier Formation Defect
Notably, we observe a tight correlation between systemic
TSLP levels, WBC counts, and degree of Notch loss in the
neonatal skin. All Notch paralogs contribute to skin homeostasis, and stepwise reduction of Notch dosage leads to
progressive skin perturbation resembling atopic dermatitis
(unpublished data). However, we ﬁnd no evidence arguing for
a speciﬁc molecular connection between Notch loss and
TSLP. Instead, the tight reverse correlation between serum
TSLP levels and Notch dosage in the skin highlights the fact
that TSLP levels reﬂect, with great precision, the magnitude
of the differentiation defects. Thus, TSLP may be a direct
readout of defects in differentiation, a systemic signal that
PLoS Biology | www.plosbiology.org

Materials and Methods
Generation of mice. Compound strains of mice were engineered as
described [14]. All animals were maintained in mixed genetic
backgrounds; however, littermates were compared whenever possible.
All mice were kept in the animal facility under Washington
University animal care regulations. In studies related to longevity,
mice were monitored regularly for sign of cachexia and failure to
thrive; care was taken to reduce competition for affected pups by
removal of wild-type littermates unnecessary for the study. Severely
affected individuals were left with their dams for their entire life
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CaCl2 to induce differentiation. After 24 h, cells and their media were
harvested for analysis.
Immunoblotting. Keratinocyte lysates in SDS were immunoblotted
to check for PS1 (H-70, Santa Cruz Biotechnology) and a-tubulin (B5–2, Sigma-Aldrich) as described [15].
Nile Red stain. Frozen skin sections, 7 lm, were stained with 0.15
mg/ml Nile Red in 75% glycerol for 2 min and counterstained with
DAPI [48].
PCR and qRT-PCR. Conventional PCR for PS1 alleles was done on
genomic DNA of most tissues. For blood, fresh or frozen blood
samples were used directly as template with KlenTaq10 (DNA
Polymerase Technology) supplemented with 1.3 M ﬁnal concentration of betaine. qRT-PCR was performed as described [15]. The
primer sequences are provided in the Text S1.
Microarray. Detailed description of microarray analyses on skin or
epidermal mRNA samples from P9 Notch-deﬁcient animals and skin
mRNA samples from wrfr–/– embryos are provided in the Supporting
Information (Text S1).
Statistical analysis. The bar graphs present the mean and standard
deviation of each measured parameter. Student’s t-test is applied as
the test of signiﬁcance unless otherwise speciﬁed.

span. Morphological details of the cutaneous phenotypes will be
published elsewhere. The following cohort of animals was analyzed:
Msx2-Cre/þ; N1 ﬂox/ﬂox (N1CKO), Msx2-Cre/þ; N1 ﬂox/ﬂox ; N2 ﬂox/þ
(N1N2hCKO), Msx2-Cre/þ; N1ﬂox/ﬂox; N2 ﬂox/þ; N3–/– (N1N2hN3CKO),
N1N2CKO, PSDCKO, RBP-jCKO, PSDRBP-jCKO, N1N2RBP-jCKO,
Prx1-Cre/þ; PS1ﬂox/ﬂox; PS2–/–, Msx2-Cre/þ; Rosa26R/þ, Msx2-Cre/þ; ZEG/þ,
CD4-Cre/þ; ZEG/þ, K14-TSLPtg. Wild-type cohorts in this study
included Cre-negative littermates, Msx2-Cre/þ; PS1ﬂox/þ; PS2–/–, Msx2Cre/þ; RBP-j ﬂox/þ, and Msx2-Cre/þ; Notch1ﬂox/þ.
Histology and imunohistochemistry. For hematoxylin-and-eosin
staining, tissue samples were ﬁxed in 4% paraformaldehyde in
phosphate-buffered saline (PBS), dehydrated in ethanol, and parafﬁnembedded. Tissues blocks were sectioned at 5 lm; Lac-Z staining on
E15.5 embryo was performed as previously described [14]. Immunostaining on parafﬁn-embedded tissue samples was performed with
the following biotinylated antibodies: anti-B220 (clone RA3-6B2, BD
Pharmingen), anti-F4/80 (Abcam), anti-CD3e (clone 145–2C11, BD
Pharmingen), and anti-TSLP (R&D Systems). Horseradish-peroxidase-conjugated streptavidin and DAB substrate kit (Pierce) were
used to visualize the signal. For RBP-j staining, anti-RBP-j antibody
(clone T6709, Institute of Immunology) was used together with
biotinylated anti-rat secondary antibody. Sections were counterstained with hematoxylin.
Serology. Serum TSLP, IL-6, and IL-7 levels were measured
according to the manufacturer’s instructions in the Quantikine
mouse TSLP, IL-6, and IL-7 ELISA kits (R&D Systems).
Antibodies and ﬂow cytometry. Single cell suspensions from
peripheral blood, BM, and spleen were prepared for FC analysis as
described [43]. The following antibodies were used: anti-B220 (RA36B2) conjugated to ﬂuorescein (FITC), phycoerythrin (PE), or
peridinin chlorophyll-a protein-cyanin 5.5 (PerCP-Cy5.5), anti-CD45
(30-F11) conjugated to PerCP-Cy5.5, anti-Ly-6G (1A8), anti-TER-119,
anti-Thy-1 (5E10), anti-CD3e (500A2), and anti-CD43 (S7) conjugated
to PE, anti-IgM (R6–60.2) conjugated to FITC and PE (all from BD
Pharmingen). Stained cells were studied using a BD FACScan
Flowcytometer (Cytek Development), and the data were analyzed
using FlowJo software.
Bone marrow transplantation. For allogeneic BMT, the immunocompetent recipient mice were lethally irradiated with 950 cGy at
;P10 and transplanted with freshly harvested, unfractionated BM
cells from their littermates as previously described [43]. However,
NOD/SCID mice received BMT after a sublethal dose of irradiation
(300 cGy). In each case, 2 3 106 cells in 100 ll of PBS þ 2% fetal bovine
serum were injected into the retro-orbital sinus of the irradiated
recipient animal. A cohort of transplanted N1N2CKO mice were
treated orally with 50 ll of 200 mg/ml cephalexin (Ranbaxy
Pharmaceuticaks) twice daily.
Disease monitoring. To study disease progression and monitor
disease occurrence/recurrence, all mutant and irradiated/transplanted mice were monitored closely over their life spans for signs
of weakness, weight loss, and morbidity. Blood samples were collected
from the mandibular vein. Hematological analysis (Hemavet 950
analyzer, Drew Scientiﬁc) comprised complete blood count including
WBCs, platelets, red blood cells, white cell differential counts, and
hemoglobin measurements [44]. White cell differential counts were
conﬁrmed on blood smears. In addition, blood samples were
collected for FC analysis. Moribund mice were euthanized, and
peripheral blood, BM, lymph nodes, thymus, lung, liver, and spleen
were collected for a comprehensive pathological analysis as described
previously [45].
TSLP injection. Wild-type mice were injected intravascularly with
carrier alone (50 ll PBS) or with carrier containing 0.5, 1, or 1.5 lg of
recombinant mouse TSLP (R&D Systems) daily for 7 d starting on P0,
P7, or P14. Mice were euthanized 12 h after the last injection, and
tissues were collected for analysis. An ELISA assay of serum measured
the systemic TSLP level. Complete blood count and FC analyses on
BM, blood, and spleen were performed to check for any sign of B-LPD.
Barrier function assay. To test barrier function defect, a dye
penetration assay was performed as previously outlined [46]. Brieﬂy,
intact E18.5 embryos were stained in X-gal (pH 4.5) for 12 h at 37 8C.
After X-gal staining and three rounds of PBS wash, the embryos were
photographed with a digital camera.
Keratinocyte culture. Primary keratinocytes were isolated from the
dorsal midline skin of newborn mutant and wild-type littermates. The
cells were maintained in 60-mm2 dishes with a medium of low
calcium concentration as previously described [47]. Keratinocytes
were plated at 40% conﬂuence and allowed to double. Conﬂuent
plates (80%) were treated with 2.5, 5, or 10 lM NFjB inhibitor (BAY
11–7082) or carrier alone (DMSO). After 24 h, cells were re-fed with
inhibitor/DMSO containing fresh medium with or without 2 mM
PLoS Biology | www.plosbiology.org

Supporting Information
Figure S1. RBP-jCKO Keratinocytes Lack RBP-j Protein
a-RBP-j antibody staining of the P0 dorsal skin from wild-type and
RBP-jCKO mice conﬁrms the absence of RBP-j protein in RBP-jCKO
keratinocytes at birth (2003 magniﬁcation). Arrowheads refer to;
black, basal layer of the epidermis; green, hair follicle; red, dermal
ﬁbroblasts.
Found at doi:10.1371/journal.pbio.0060123.sg001 (3.5 MB JPG).
Figure S2. Phenotypes of Notch-Deﬁcient Mice before and after BMT
(A) B220þ B-lymphocytes inﬁltrate vital organs of P14 mutant animal
(2003 magniﬁcation). Note that B-lymphocytes have ﬁlled the bone
marrow, interfering with normal hematopoiesis and contributing to
the anemia and thrombocytopenia in mutant animals.
(B) Substantial cryoglobulin formation is detected in the mutant
serum after incubating the sera at 4 8C for 48 h.
(C) Dorsal and ventral views of BMT-rescued animals show that
PSDCKO mice have a faster progressing skin disease than N1N2CKO
mice. Due in part to this skin phenotype, BMT-rescued PSDCKO
mice have a shorter life span than N1N2CKO mice, reaching the
terminal stage at P40.
Found at doi:10.1371/journal.pbio.0060123.sg002 (3.7 MB JPG).
Figure S3. FC Analysis on Peripheral Blood Samples from N1N2CKO
and RBP-jCKO Mice
Comparing the proﬁles obtained at P12 with those seen at P78
demonstrates the transition from B-LPD (P12) to granulocytosis (P78)
relative to wild-type controls. B-lymphocyte, T-lymphocyte, and
granulocyte/monocyte percentages are shown in blood. Note that to
allow the N1N2CKO animal to reach P78 this individual has
undergone BMT at P10 and has been receiving daily antibiotic
treatment.
Found at doi:10.1371/journal.pbio.0060123.sg003 (6.9 MB JPG).
Figure S4. Delay in B-LPD Surge Increased Life Span of the Mutant
Mice
(A) Either sublethal dose of total body irradiation (;450 cGy) or focal
irradiation of liver or thymus signiﬁcantly extended life span of
N1N2CKO and PSDCKO mice (n ¼ 3 per genotype for each treatment
group; p , 0.01, log rank test). Note that N1N2CKO mice live longer
than PSDCKO mice, most likely due to a milder skin phenotype.
(B) Monitoring WBC count shows that B-LPD, although delayed,
surges in N1N2CKO and PSDCKO mice receiving sublethal or focal
irradiation.
Found at doi:10.1371/journal.pbio.0060123.sg004 (1.1 MB JPG).
Figure S5. Documenting the Success of BMT by Genotyping
DNA from peripheral blood of recipient animals analyzed for the
presence of PS1 alleles 25 d after BMT conﬁrms repopulation of the
recipients’ hematopoietic system by donor-derived BM cells in both
(A) rescue and (B) disease propagation experiments. Because there is
no Cre activity in the hematopoietic system, the difference between
homozygous (one band) and heterozygous (two bands) is detected.
Controls for the various genotypes are shown in (B).
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Found at doi:10.1371/journal.pbio.0060123.sg005 (2.1 MB JPG).

that mutant mice are smaller than their wild-type littermates yet have
larger spleen and lymph nodes (n ¼ 3, for each group). The values are
presented as mean 6 standard deviation (‘‘a’’ indicates p , 0.001
(compared to wild-type control)).
Found at doi:10.1371/journal.pbio.0060123.st001 (35 KB PDF).

Figure S6. NOD/SCID Mice That Receive BM from the Mutant
Animals Do Not Develop B-LPD
(A) NOD/SCID mice receiving BM from mutant or wild-type newborn
donors are indistinguishable over 2 mo of follow-up.
(B) The percentage of B220þ B cells in mice receiving BM from
mutant or wild-type donors is not signiﬁcantly different.
(C) Genotyping for PS1 alleles in peripheral blood from NOD/SCID
mice 25 days after BMT shows that most of their WBCs are derived
from the donor BM.
Found at doi:10.1371/journal.pbio.0060123.sg006 (3.3 MB JPG).

Table S2. Data for the Skin Microarray Trend Analysis Shown in
Figure S6
Values are shown as log of fold change. Down-regulated genes are
labeled with a minus sign.
Found at doi:10.1371/journal.pbio.0060123.st002 (44 KB PDF).
Table S3. Serum Analysis of the Mutant Animals
Comprehensive (A) antigen and (B) autoimmune analysis on sera
collected from P14 mutant (N1N2CKO; n ¼ 3) and wild-type (n ¼ 3)
animals does not identify any other factor besides TSLP that could
potentially explain B-LPD in the mutant animals. The antigens with
signiﬁcantly higher levels in mutant serum are marked (values in red).
Note that the least detectable dose for each factor is calculated as
three standard deviations above the average value obtained measuring 20 blank samples. Therefore, values below the least detectable
dose are below accurate detection range. Rules Based Medicine
laboratory cutoff values for autoimmune analysis signify the upper
limits of normal ratios for each factor measured.
Found at doi:10.1371/journal.pbio.0060123.st003 (46 KB PDF).

Figure S7. Trend Analysis of Microarray Data
Cytokines/chemokines that are up- or down-regulated in P9 mutant
versus wild-type skin mRNA samples are enriched by this analysis.
Note the absence of TNFa.
Found at doi:10.1371/journal.pbio.0060123.sg007 (2.7 MB JPG).
Figure S8. TSLP Immunostaining of P5 Dorsal Skin
PSDCKO mice produce TSLP in suprabasal keratinocytes whereas
wild-type mice do not (dashed lines demarcate the basement
membrane; 2003 magniﬁcation). For immunoﬂorescence, Cy-3conjugated streptavidin is used to detect biotinylated a-TSLP, and
sections are counterstained with DAPI nuclear stain.
Found at doi:10.1371/journal.pbio.0060123.sg008 (729 KB JPG).

Table S4. Changes in Selected Group of Lipid Metabolic Enzymes
from PSDCKO and Wild-Type Epidermal Microarray
For comparison, TSLP probes also are included. The color highlights
samples with p , 0.005.
Found at doi:10.1371/journal.pbio.0060123.st004 (59 KB PDF).

Figure S9. Tight Correlation between Serum TSLP Levels and WBC
Counts in the Newborn Mice
Comparing (A) the serum TSLP levels and (B) WBC counts of all
animal cohorts examined in this study (compiled from the data shown
in Figure 1, 5, and 6) reveals a tight correlation between the systemic
TSLP elevation and WBC count increase in newborn mice. The
measurements are obtained from mutant mice in the second week of
life and from TSLP-treated wild-type animals at P8 (n ¼ 3, for each
group; signiﬁcant difference between adjacent genotypes is highlighted: *, p , 0.05, **, p , 0.01).
Found at doi:10.1371/journal.pbio.0060123.sg009 (1.3 MB JPG).

Text S1. Supplemental Materials and Methods
Found at doi:10.1371/journal.pbio.0060123.sd001 (54 KB DOC).
Accession numbers
Accession numbers for genes mentioned in this paper from the
National Center for Biotechnology Information (http://www.ncbi.nlm.
nih.gov) are FATP4 (AJ276492), NFjB (AY521463), Notch1
(NM_008714), Notch2 (NM_010928), Notch3 (NM_008716), PS1
(NM_008943), PS2 (NM_011183), RBP-j, (NM_009035), and TSLP
(NM_021367).

Figure S10. Fetal Liver Transplantation Cures B-LPD in NotchDeﬁcient Animals
(A) Monitoring the WBC counts of the transplanted mice shows no BLPD recurrence in the mutant animals after FLT (n ¼ 3, for each
group).
(B) DNA from peripheral blood of transplanted N1N2CKO animals,
analyzed for the presence of Notch1 alleles 25 days after FLT, conﬁrms
the repopulation of the recipients’ hematopoietic system by donorderived fetal liver cells.
(C) FC analysis on peripheral blood from transplanted N1N2CKO,
RBP-jCKO, and wild-type mice collected 25 days after FLT shows no
sign of B cell expansion in the mutant animals.
(D) As with BMT, curing lethal B-LPD in N1N2CKO animals by FLT
(n ¼ 3) leads to a relative extension in life span compared to
untransplanted N1N2CKO mice (n ¼ 20; p , 0.001, log rank test).
Found at doi:10.1371/journal.pbio.0060123.sg010 (1.5 MB JPG).
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